COMMUNIQUÉS West-GlobeNewswire

Zealand increases its share capital as a consequence of exercise of employee warrants
15/06/2017
Copenhagen, June 15, 2017 - Zealand Pharma ("Zealand") has increased its share capital by a nominal amount of DKK 8,537 divided into 8,537 new shares with a nominal value of DKK 1 each. The increase is a consequence of [...]
ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today
15/06/2017
Zutphen, The Netherlands, 15 June 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a third Packed Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]
Novartis' Cosentyx shows sustained improvements in signs and symptoms for both AS and PsA in up to 80% of patients at 3 years
15/06/2017
Cosentyx ® is the first and only IL-17A inhibitor to show sustained improvements in signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA)[1],[2] Additional data show rapid and sustained pain [...]
TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis
15/06/2017
PRESS RELEASE TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis - Joins the Crohn's and Colitis Foundation's President's Corporate Circle - Signs [...]
INNATE PHARMA : Dose-escalation data show favorable safety profile and promising clinical activity for IPH4102
15/06/2017
DOSE-ESCALATION DATA SHOW favorable SAFETY PROFILE AND PROMISING CLINICAL ACTIVITY FOR IPH4102 Oral presentation on the dose-escalation part of a Phase I trial at the International Conference on Malignant Lymphoma (ICML [...]
INNATE PHARMA : Résultats d'escalade de dose d'IPH4102 : Profil de tolérance et activité clinique prometteurs
15/06/2017
rÉsultats d'escalade de dose d'IPH4102 : profil de tolÉrance et activitÉ clinique prometteurs La partie en escalade de dose de l'essai de Phase I a fait l'objet d'une présentation orale lors de l'ICML [1] à Lugano ; [...]
Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan
15/06/2017
Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan Paris, France - June 15, 2017 - Sanofi announced today the launch of "Action 2017", a worldwide stock purchase plan reserved for its employees. In [...]
Sanofi lance « Action 2017 », un plan mondial d'actionnariat salarié
15/06/2017
Sanofi lance « Action 2017 », un plan mondial d'actionnariat salarié Paris, France - Le 15 juin 2017 - Sanofi annonce aujourd'hui le lancement d' « Action 2017 », un plan mondial d'actionnariat salarié. En procédant à [...]
Basilea announces license agreement with Pfizer for antifungal Cresemba® (isavuconazole) for Europe, Russia, Turkey and Israel
14/06/2017
Press release (PDF) This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]
SPINEWAY enregistre une nouvelle commande d'1 M$ aux USA
14/06/2017
Communiqué de presse Ecully, le 14 juin 2017 SPINEWAY enregistre une nouvelle commande d'1 M$ aux USA Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la colonne [...]
SPINEWAY records a new $1M order in the USA
14/06/2017
Press release Ecully, 14 June 2017 SPINEWAY records a new $1M order in the USA Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has obtained a new order via [...]
Guerbet investit dans le fonds de Truffle Capital dédié aux dispositifs médicaux et biotechnologies
14/06/2017
Villepinte, le 14 juin 2017 - 18:00 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale annonce avoir signé une prise de participation d'un montant de quinze [...]
Guerbet invests in the Truffle Capital fund dedicated to medical devices and biotechnologies
14/06/2017
Villepinte, June 14, 2017 - 6:00 pm CEST - Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, today announced that it has signed an equity acquisition of fifteen [...]
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
14/06/2017
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...
14/06/2017
Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]
Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson
14/06/2017
ALLSCHWIL/BASEL, SWITZERLAND - 14 June 2017 - Actelion Ltd (SIX: ATLN) today announced changes to its executive team that will take effect upon the settlement of the public tender offer by Johnson & Johnson's Swiss [...]
Ordinary General Meeting of Shareholders of Probiodrug AG
14/06/2017
Ordinary General Meeting of Shareholders of Probiodrug AG All proposed resolutions approved with large majority HALLE (SAALE), Germany, 14 June 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company [...]
Ordinary General Meeting of Shareholders of Probiodrug AG
14/06/2017
Ordinary General Meeting of Shareholders of Probiodrug AG All proposed resolutions approved with large majority HALLE (SAALE), Germany, 14 June 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company [...]
Silmäasema Oyj: 10 largest shareholders after the end of the Initial Public Offering
14/06/2017
Stock Exchange Release 14 June 2017, at 4.30 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE OR JAPAN OR ANY [...]

Pages